Proteome Sciences plc (AIM:PRM)
London
· Delayed Price · Currency is GBP · Price in GBX 2.600
-0.200 (-7.14%)
At close: Dec 5, 2025
Proteome Sciences Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 4.53 | 4.89 | 5.03 | 7.78 | 5.13 | 4.75 | Upgrade
|
| Revenue Growth (YoY) | 12.19% | -2.80% | -35.37% | 51.69% | 7.91% | 2.08% | Upgrade
|
| Cost of Revenue | 3.74 | 4.22 | 3.38 | 3.01 | 2.17 | 2.17 | Upgrade
|
| Gross Profit | 0.79 | 0.67 | 1.65 | 4.77 | 2.96 | 2.59 | Upgrade
|
| Selling, General & Admin | 2.24 | 2.19 | 2.78 | 2.64 | 2.34 | 2.04 | Upgrade
|
| Operating Expenses | 3.06 | 3.02 | 3.27 | 3.04 | 2.55 | 2.04 | Upgrade
|
| Operating Income | -2.27 | -2.35 | -1.62 | 1.73 | 0.41 | 0.55 | Upgrade
|
| Interest Expense | -0.9 | -0.9 | -0.8 | -0.47 | -0.29 | -0.3 | Upgrade
|
| Pretax Income | -3.17 | -3.25 | -2.42 | 1.26 | 0.12 | 0.25 | Upgrade
|
| Income Tax Expense | 0.16 | 0.16 | 0.03 | -0.07 | 0.05 | -0.05 | Upgrade
|
| Net Income | -3.33 | -3.41 | -2.44 | 1.33 | 0.07 | 0.3 | Upgrade
|
| Net Income to Common | -3.33 | -3.41 | -2.44 | 1.33 | 0.07 | 0.3 | Upgrade
|
| Net Income Growth | - | - | - | 1740.28% | -75.59% | 97.99% | Upgrade
|
| Shares Outstanding (Basic) | 295 | 295 | 295 | 295 | 295 | 295 | Upgrade
|
| Shares Outstanding (Diluted) | 295 | 307 | 311 | 309 | 302 | 295 | Upgrade
|
| Shares Change (YoY) | - | -1.25% | 0.71% | 2.38% | 2.26% | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | Upgrade
|
| EPS Growth | - | - | - | 2060.30% | -80.08% | 100.20% | Upgrade
|
| Free Cash Flow | -1.48 | -1.05 | -0.72 | 1.82 | 0.59 | 1.57 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.00 | 0.01 | 0.00 | 0.01 | Upgrade
|
| Gross Margin | 17.43% | 13.71% | 32.76% | 61.27% | 57.71% | 54.39% | Upgrade
|
| Operating Margin | -50.12% | -48.15% | -32.24% | 22.21% | 8.03% | 11.55% | Upgrade
|
| Profit Margin | -73.63% | -69.69% | -48.59% | 17.03% | 1.40% | 6.21% | Upgrade
|
| Free Cash Flow Margin | -32.74% | -21.49% | -14.28% | 23.41% | 11.48% | 33.03% | Upgrade
|
| EBITDA | -2.14 | -2.2 | -1.5 | 1.83 | 0.45 | 0.58 | Upgrade
|
| EBITDA Margin | -47.16% | -45.08% | -29.79% | 23.57% | 8.81% | 12.22% | Upgrade
|
| D&A For EBITDA | 0.13 | 0.15 | 0.12 | 0.11 | 0.04 | 0.03 | Upgrade
|
| EBIT | -2.27 | -2.35 | -1.62 | 1.73 | 0.41 | 0.55 | Upgrade
|
| EBIT Margin | -50.12% | -48.15% | -32.24% | 22.21% | 8.03% | 11.55% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 38.98% | - | Upgrade
|
| Revenue as Reported | 4.89 | 4.89 | 5.03 | 7.78 | 5.13 | 4.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.